AbbVie Inc. v. Medimmune Limited > Summary
Court Case Number 2017-1689
Filing Date Feb 27, 2017
Termination Date Feb 5, 2018
Appeal From DCT
NOS 830
Status Terminated
Court U.S. Court Of Appeals, Federal Circuit
Appellee
Appellant Attorneys
10AbbVie Inc.
Attorney Name: Jeffrey I. Weinberger
Munger Tolles & Olson
AbbVie Inc.
Attorney Name: Ginger D. Anders
Munger Tolles & Olson
AbbVie Inc.
Attorney Name: David P. Frazier
Latham & Watkins
AbbVie Inc.
Attorney Name: Michael A. Morin
Latham & Watkins
AbbVie Inc.
Attorney Name: Heather E. F. Takahashi
Munger Tolles & Olson
AbbVie Biotechnology
Attorney Name: Jeffrey I. Weinberger
Munger Tolles & Olson
AbbVie Biotechnology
Attorney Name: Ginger D. Anders
Munger Tolles & Olson
AbbVie Biotechnology
Attorney Name: David P. Frazier
Latham & Watkins
AbbVie Biotechnology
Attorney Name: Michael A. Morin
Latham & Watkins
AbbVie Biotechnology
Attorney Name: Heather E. F. Takahashi
Munger Tolles & Olson
Appellee Attorneys
3MEDIMMUNE (Astrazeneca)
Attorney Name: David I. Berl
Williams & Connolly
MEDIMMUNE (Astrazeneca)
Attorney Name: Thomas S. Fletcher
Williams & Connolly
MEDIMMUNE (Astrazeneca)
Attorney Name: Shaun P. Mahaffy
Williams & Connolly